Earnings, Financial industry & Stock markets | Finance news

Actelion, being bought by J&J, says full year core net income rose 27 perc...

ZURICH Swiss drugmaker Actelion's (ATLN. S) 2016 core net income rose 27 percent on accelerating sales of its newer medicines to treat deadly pulmonary arterial hypertension (PAH), it said on Tuesday. Core net income rose to 881 million Swiss francs ($877.8 million) from 693 million francs in the previous year, the company said in a statement. Sales rose 18 percent to 2.42 billion francs, in line with the 2.41 billion francs expected in a Reuters poll.

Actelion reported that sales of its new drug Opsumit for PAH rose 57 percent to 831 million francs, while Uptravi booked 245 million francs in its first year after launch, more than making up for slumping sales of its once-mainstay Tracleer after patent expiration. Europe's biggest biotech sold itself for $30 billion to U.S. healthcare giant Johnson & Johnson (JNJ. N) this year, in a deal that will also create a new research and development company to be overseen by Actelion Chief Executive Jean-Paul Clozel.

"Our current PAH portfolio and our late-stage pipeline will have expanded potential as part of Johnson & Johnson," Clozel said. "With the creation of a new R&D company we also have the opportunity to realize the value potential we have created with our discovery engine and early-stage pipeline."

Ford to invest $1 billion in autonomous vehicle tech firm Argo AI

Ford Motor Co plans to invest $1 billion over the next five years in tech startup Argo AI to help the Detroit automaker reach its goal of producing a self-driving vehicle for commercial ride sharing fleets by 2021, the companies announced on Friday. The investment in Pittsburg-based Argo AI, founded by former executives on self-driving teams at Google and Uber, will make Ford the company's largest shareholder. Ford Chief Executive Officer Mark Fields said the investment is in line with previous announcements on planned capital expenditures. Argo AI, which focuses on artificial intelligence and robotics, will help build what Ford calls its "virtual driver system" at the heart of the fully autonomous car Ford said last year it would develop by 2021.

"With Argo AI’s agility and Ford's scale we're combining the benefits of a technology start up with the experience and discipline we have at Ford," Fields said at a press conference. Once the technology is fully developed for Ford, it could be licensed to other companies, executives said.

While Ford will retain a majority of the start-up's equity, the potential for an equity stake as Argo AI hires 200 more employees will be an advantage in recruiting talent, executives said."They have the opportunity to run it pretty independently with a board, but because it is a separate company or subsidiary, it has the opportunity to go out and recruit with competitive compensation packages and equity," Fields said.

Until now, Ford's investments in future transportation technology have been relatively modest, compared with those of General Motors Co and others. One of Ford’s largest such investments in the past year was $75 million to buy a minority stake in Velodyne, a manufacturer of laser-based lidar sensing systems for self-driving cars. Rival GM made a billion-dollar bet a year ago with its acquisition of Silicon Valley self-driving startup Cruise Automation. GM also invested $500 million to buy a 9-percent stake in San Francisco-based ride services firm Lyft, a competitor to Uber.